Skip to main content
Rajeev Vibhakar, MD, Pediatric Hematology & Oncology, Aurora, CO

Rajeev Vibhakar MD


Professor, Pediatrics, University of Colorado School of Medicine

Join to View Full Profile
  • 13123 E 16th AveAurora, CO 80045

  • Phone+1 720-777-1234

Dr. Vibhakar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsFellowship, Pediatric Hematology/Oncology, 2002 - 2005
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Pediatrics, 1999 - 2002
  • New York Medical College
    New York Medical CollegeClass of 1999

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2009 - 2025
  • IA State Medical License
    IA State Medical License 1999 - 2010
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Press Mentions

  • Sujatha Venkataraman, PhD, Receives Funding for Pediatric Brain Cancer Research
    Sujatha Venkataraman, PhD, Receives Funding for Pediatric Brain Cancer ResearchJanuary 30th, 2025
  • CU Cancer Center Scientific Retreat Spotlights Successes, Challenges
    CU Cancer Center Scientific Retreat Spotlights Successes, ChallengesSeptember 30th, 2024
  • CU Cancer Center Researchers Receive PRCRP Grant to Investigate Metastasis
    CU Cancer Center Researchers Receive PRCRP Grant to Investigate MetastasisApril 27th, 2021
  • Join now to see all

Grant Support

  • Mechanisms of resistance to WEE1 inhibition in Myc driven medulloblastomaUNIVERSITY OF COLORADO DENVER2015–2026
  • Mechanisms of resistance to WEE1 inhibition in Myc driven medulloblastomaUNIVERSITY OF COLORADO DENVER2015–2026
  • Mechanisms of resistance to WEE1 inhibition in Myc driven medulloblastomaUNIVERSITY OF COLORADO DENVER2015–2026
  • Selective targeting of ependymoma progenitor cells via BMI1 inhibitionUNIVERSITY OF COLORADO DENVER2023–2025
  • Selective targeting of ependymoma progenitor cells via BMI1 inhibitionUNIVERSITY OF COLORADO DENVER2023–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: